Good morning, everyone. Nice to see you again. A mellow morning here on the Pharmalot corporate campus, where the short people are sleeping in, because the local schoolhouses are closed. This gives us time to brew that extra cup of desired stimulation and, of course, get organized for another busy day. So why delay? Here are a few tidbits to get us all started.And by the way, please tune in to our next webinar in which former CNBC reporter and public relations expert Mike Huckman next Thursday will talk about how pharma can cope with media coverage ( see this). Meanwhile, have a great day...
J&J Remains Short Of Doxil Cancer Drug (Dow Jones)
Ranbaxy May Resolve FDA Dispute And Ship Generic Lipitor (Bloomberg News)
Mylan Pays $17.5M For Pfizer Version Of Advair (Pharma Times)
Roche Wins $1.7M In Property Tax Appeal (NorthJersey.com)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr